Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficiency (Details Textual)

v2.4.0.8
Stockholders' Deficiency (Details Textual) (USD $)
0 Months Ended 1 Months Ended 3 Months Ended 9 Months Ended 1 Months Ended
Jul. 07, 2014
Jul. 29, 2014
Jun. 30, 2014
Sep. 30, 2014
Sep. 30, 2013
Jun. 30, 2014
Warrant [Member]
Sep. 30, 2014
Warrant [Member]
Stock Issued During Period, Shares, New Issues       4,090,661      
Stockholders Equity Note Description       Each unit was sold for $0.75 per unit and consisted of one share of common stock and an immediately vested five-year warrant to purchase one share of common stock at an exercise price of $0.75 per share.      
Reclassification Of Warrants To Derivative Liability       $ 1,499,000 $ 0    
Share Price       $ 0.75      
Class of Warrant or Right, Exercise Price of Warrants or Rights     $ 0.75 $ 0.75   $ 0.75 $ 0.75
Proceeds from Issuance of Common Stock       3,067,996      
Equity Financing Issuance Costs       55,150      
Stock Issued During Period, Shares, Issued for Services 100,000 100,000          
Stock Issued During Period, Value, Issued for Services     43,000        
Proceeds From Issuance Of Common Stock And Warrants, Net       3,012,846 [1] 0 [1]    
Conversion of Stock, Shares Issued       233,333 [1]      
Warrants and Rights Outstanding     $ 6,903,159 $ 420,000      
Warrants To Purchase Common Stock       400,000   4,859,324  
[1] Net of $55,150 of issuance costs.